Procter & Gamble Health Limited announced that the Board of Directors of the Company, at its meeting held March 17, 2023 have appointed Mr. Lokesh Chandak as Chief Financial Officer and Additional (Executive) Director of the Company effective April 1, 2023. His appointment as Director is subject to allotment of Director Identification Number by the Ministry of Corporate Affairs. Mr. Chandak will hold office as Additional Director up to the upcoming Annual General Meeting.

Mr. Lokesh Chandak is a Chartered Accountant and a Company Secretary. He comes with an experience of over 15 years in finance and accounting across multiple geographies. He has spent the last 13 years with Procter & Gamble (P&G) across 3 geographies, multiple businesses and leading various projects having significant impact on business and controls.

In his last role, Mr. Lokesh Chandak was Director - Commercial Finance & Stewardship, India Consumer Health & Director - Stewardship, Personal Health Care (Asia, Middle East & Africa) of the Company for three years. He led several strategic and structural changes, transformational projects across areas amidst significant market disruption with turnaround in top and bottom line for India Consumer Health and Stewardship for Asia, Middle East & Africa. Mr. Chandak was also appointed as Internal Auditor of the Company for the past 2 years.

Prior to that, Mr. Chandak was Director Finance Indonesia Manufacturing Operation (Fabric and Hair care business unit), where he led significant breakthroughs in profitability improvement through cost savings initiatives across supply chain. He also led innovation ideas driving topline growth and enabling investments in business to drive growth.